Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-064750
Filing Date
2025-07-01
Accepted
2025-07-01 16:30:15
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2519519-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2519519-1_4seq1.xml 4 2031
  Complete submission text file 0001104659-25-064750.txt   3616
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET, SUITE B1-1 CAMBRIDGE MA 02141
Business Address
O'Mahony John Mark (Reporting) CIK: 0001808556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 251096814